Immunoglobulin G (IgG) is the most abundant antibody isotype in serum and extracellular fluid, comprising approximately 75-80% of total serum antibodies. This monomeric Y-shaped glycoprotein provides long-term humoral adaptive immunity through multiple effector mechanisms: opsonization via Fc receptor binding, complement system activation through C1q, ADCC via NK cells, and direct neutralization of toxins and viruses. IgG uniquely crosses the placenta via FcRn (neonatal Fc receptor) to confer passive immunity to the developing fetus.
Think of IgG as the veteran security consultant of your immune army—not the first responder, but the experienced professional who arrives after initial reconnaissance and stays for the long haul. When IgM (the rookie patrol officer) first spots trouble, it calls in backup and begins establishing a perimeter. Days later, IgG arrives with specialized equipment: it doesn't just identify criminals (pathogens), it tags them with bright orange paint (opsonization) so patrol officers (macrophages, neutrophils) can spot them instantly. It also carries master keys that unlock the complement system's weaponry vault, and it briefs the special forces (NK cells) on exactly which tagged targets to eliminate. Unlike IgM who works in teams of five (pentameric), IgG works solo but is four times more numerous and stays on patrol for 3-4 weeks (half-life 21-28 days) versus IgM's 5-day shift. IgG has four slightly different uniforms (IgG1-4 subclasses), each specialized for different threats—IgG1 and IgG3 are the "heavy hitters" with full complement activation, while IgG4 is the diplomatic corps that prefers negotiation over warfare.
IgG antibodies are synthesized by plasma cells (terminally differentiated B cells) following antigen-driven class switching from IgM. The molecular architecture consists of:
Structural domains:
- Two heavy chains (γ-chains) and two light chains (κ or λ)
- Two Fab regions (Fragment antigen-binding) containing variable domains (VH + VL) for antigen recognition
- One Fc region (Fragment crystallizable) containing constant domains (CH2 + CH3) for effector functions
- Hinge region between Fab and Fc allowing conformational flexibility
Subclass-specific properties:
- IgG1 (60-70%): binds all FcγR subtypes, activates complement efficiently (C1q affinity high)
- IgG2 (20-30%): preferentially responds to polysaccharide antigens, lower FcγR binding
- IgG3 (5-8%): highest complement activation, shortest half-life (7 days), extended hinge region
- IgG4 (3-6%): does not activate complement, tolerogenic role, can undergo Fab-arm exchange
Effector mechanism cascade:
graph TD
A[IgG binds antigen] --> B[Fc region exposed]
B --> C1[Classical complement pathway]
B --> C2["FcγR binding on phagocytes"]
B --> C3["FcγRIII on NK cells"]
C1 --> D1[C1q binds to Fc]
D1 --> D2[C1q-C1r-C1s complex]
D2 --> D3[C3 convertase formation]
D3 --> D4["MAC assembly → lysis"]
C2 --> E1["FcγRI/IIa/III engagement"]
E1 --> E2[ITAM phosphorylation]
E2 --> E3[Syk kinase activation]
E3 --> E4["Phagocytosis + respiratory burst"]
C3 --> F1["CD16/FcγRIIIa crosslinking"]
F1 --> F2[Perforin/granzyme release]
F2 --> F3[Target cell apoptosis]
B --> G[FcRn binding in acidic endosome]
G --> H[Recycling to cell surface]
H --> I[Release at neutral pH]
I --> J[Extended half-life 21-28 days]
Molecular details of key pathways:
-
Complement activation: Requires hexameric IgG clusters on antigen surface → C1q binds via CH2 domain → C1r and C1s serine proteases activate → cleaves C4 and C2 → forms C3 convertase (C4b2a) → amplification cascade → C5a anaphylatoxin + Membrane Attack Complex
-
Opsonization: FcγRI (CD64, high-affinity, binds monomeric IgG), FcγRIIa (CD32a, low-affinity, requires immune complexes), FcγRIIIa (CD16a on NK/macrophages) → ITAM (immunoreceptor tyrosine-based activation motif) phosphorylation by Src kinases → Syk recruitment → PI3K and PLCγ activation → actin polymerization + phagosome formation + NADPH oxidase assembly → Reactive Oxygen Species production
-
ADCC mechanism: IgG-opsonized target cell + NK cell FcγRIIIa → receptor crosslinking → ZAP70/Syk activation → calcium influx → granule exocytosis → perforin pore formation + granzyme B entry → caspase-3 activation → target apoptosis
-
FcRn-mediated recycling: IgG internalized via pinocytosis → acidic endosome (pH 6.0) → FcRn binds IgG at CH2-CH3 interface → trafficking to cell surface → neutral pH (7.4) → IgG release → mechanism explains 21-28 day half-life (longest of all antibodies)
Class switching to IgG: Activated B cell + T helper signals (CD40L-CD40 + IL-4/IL-10/IFN-γ) → activation-induced cytidine deaminase (AID) → DNA recombination at switch regions → Cμ (IgM) replaced with Cγ (IgG) → cytokine environment determines subclass (IL-4 → IgG4, IFN-γ → IgG1/IgG3)
In cPNI practice, IgG antibodies serve as critical diagnostic and therapeutic targets:
Chronic infection detection: Elevated pathogen-specific IgG (without concurrent IgM) indicates established or past infection rather than acute exposure. Examples: Epstein-Barr Virus (EBV) IgG-VCA positive with IgG-EBNA indicates remote infection; persistent high EBV IgG-EA (early antigen) suggests reactivation. Helicobacter pylori IgG remains elevated for years post-eradication, requiring correlation with CRP, calprotectin, or urea breath test. Chronic Mycoplasma pneumoniae (walking pneumonia) may show only IgG elevation with ongoing fatigue—connects to chronic fatigue syndrome and mitochondrial dysfunction.
Food sensitivity testing (controversial): IgG food panels measure IgG1-4 antibodies to dietary proteins, marketed as "delayed hypersensitivity" tests. Clinical reality: IgG to foods (especially IgG4) may represent tolerance rather than pathology—healthy individuals eating diverse diets produce IgG to common foods. However, in context of leaky gut (Intestinal permeability), elevated food-specific IgG may indicate chronic antigen exposure through damaged tight junctions. Critical distinction: IgG ≠ IgE (true allergy). Clinical use requires correlation with elimination-rechallenge protocols and barrier repair (zinc, Vitamin D, butyrate, L-glutamine). Connects to Metamodel 0 (evolutionary mismatch—processed foods as novel antigens) and Metamodel 1 (barrier dysfunction).
Autoimmune disease markers: Most autoimmune disease involves IgG autoantibodies against self-antigens:
Autoimmune IgG production reflects failure of central/peripheral tolerance mechanisms—connects to molecular mimicry (pathogen epitopes resembling self-antigens), chronic inflammation (IL-6, TNF-α driving plasma cell survival), and Th1-Th2 balance dysregulation.
Vaccination efficacy: Long-lasting IgG response (>6 months post-vaccination) indicates successful immunological memory formation. Protective thresholds vary: anti-tetanus toxoid IgG >0.1 IU/mL = protective; anti-measles IgG >200 mIU/mL = immune. Poor IgG response suggests immune senescence (immunosenescence), nutritional deficiencies (Vitamin D <30 ng/mL, Zinc <70 μg/dL), or chronic stress (elevated cortisol inhibits B cell function).
IgG subclass deficiencies: Normal total IgG but low subclasses causes recurrent infections:
- IgG2 deficiency: recurrent sinopulmonary infections (impaired response to encapsulated bacteria like Streptococcus pneumoniae)
- IgG3 deficiency: viral susceptibility (reduced antiviral immunity)
- IgG4-related disease: paradoxical—elevated IgG4 with eosinophilia causes fibrotic infiltration of organs (pancreas, retroperitoneum)
Therapeutic interventions:
- Barrier repair protocols reduce food-specific IgG: betaine HCl, digestive enzymes, Zinc, L-glutamine, omega-3 fatty acids
- Chronic infection reactivation management: optimize Vitamin D (target 50-80 ng/mL), melatonin for viral suppression, adaptogenic support (Ashwagandha, Rhodiola)
- Autoimmune IgG reduction: address upstream triggers (dysbiosis, chronic stress, gluten in genetically susceptible), consider low-dose Naltrexone (modulates B cell activity via opioid receptors)
Connects to evolutionary medicine: IgG represents investment in long-term adaptive immunity—costly to produce but essential for pathogen memory in pre-antibiotic environments. Modern hygiene (reduced pathogen exposure) may skew toward inappropriate IgG responses to benign antigens (food, commensal bacteria)—supports Hygiene Hypothesis. Maternal IgG transfer via placenta = evolutionary adaptation ensuring neonatal protection during immune immaturity (connects to breastfeeding and sIgA in colostrum).
- Comprises 75-80% of total serum antibodies in adults (9-16 g/L in serum)
- Half-life of 21-28 days (IgG1, IgG2, IgG4) or 7 days (IgG3) — longest persistence of all immunoglobulin classes
- Only antibody that crosses placenta via FcRn receptor — provides fetal immunity for first 3-6 months of life
- Four subclasses with distinct functions: IgG1 (60-70%, broad pathogen responses), IgG2 (20-30%, polysaccharide antigens), IgG3 (5-8%, strongest complement activation), IgG4 (3-6%, tolerance/allergy resolution)
- IgG1 and IgG3 efficiently activate classical complement system via C1q binding (requires hexameric antibody clusters on antigen surface)
- IgG4 does not activate complement and cannot mediate ADCC — considered "blocking antibody" in allergy immunotherapy
- FcγRI (CD64) binds monomeric IgG with high affinity (Kd ~10⁻⁹ M), present on macrophages/monocytes
- FcγRIIa (CD32a) and FcγRIIIa (CD16a) are low-affinity receptors requiring immune complexes for activation
- Peak IgG production occurs 10-14 days post-antigen exposure (secondary response) or 3-4 weeks (primary response)
- Normal serum levels: IgG1 (4.9-11.4 g/L), IgG2 (1.5-6.4 g/L), IgG3 (0.2-1.1 g/L), IgG4 (0.08-1.4 g/L)
- IgG deficiency (<7 g/L total) increases infection risk — common variable immunodeficiency (CVID) if B cells present but non-functional
- Elevated total IgG (>16 g/L) suggests chronic infection, autoimmunity, or monoclonal gammopathy (multiple myeloma)
- Anti-nuclear antibodies (ANA) are predominantly IgG — titer >1:160 clinically significant for autoimmune diseases
- IgG food antibodies peak 4-7 days post-ingestion (delayed hypersensitivity timeline) versus IgE (immediate <2 hours)
- Intravenous immunoglobulin (IVIG) therapy uses pooled donor IgG to treat antibody deficiencies and modulate autoimmune responses
- B cells — IgG-producing plasma cells are terminally differentiated B cells arising from germinal center reactions after antigen-driven selection and class switching
- adaptive immunity — IgG represents the "memory arm" of humoral immunity, providing antigen-specific protection lasting months to years
- complement system — IgG (subclasses 1, 2, 3) activates classical pathway via C1q binding to Fc regions, amplifying pathogen lysis
- opsonization — IgG coating of pathogens promotes phagocytosis by macrophages and neutrophils via FcγR recognition
- ADCC — IgG-opsonized target cells are killed by NK cells through FcγRIIIa (CD16) engagement triggering perforin/granzyme release
- NK cells — mediate antibody-dependent cellular cytotoxicity against IgG-coated virus-infected or tumor cells
- macrophages — express FcγRI and FcγRIIa for high-efficiency phagocytosis of IgG-opsonized pathogens and immune complexes
- IgA — complementary antibody roles; IgG dominates systemic/blood immunity while IgA protects mucosal surfaces (gut, respiratory)
- IgM — pentameric "first responder" antibody (acute infection marker) versus monomeric IgG indicating established/past exposure and memory
- autoimmune disease — chronic autoimmune conditions feature pathogenic IgG autoantibodies (anti-dsDNA in Systemic lupus erythematosus, ACPA in Rheumatoid arthritis)
- food sensitivities — IgG food panels detect delayed reactions, though clinical validity debated; elevated IgG may reflect Intestinal permeability not true allergy
- chronic infections — persistent pathogen-specific IgG (e.g., EBV, Helicobacter pylori) indicates chronic/past infection requiring clinical correlation
- vaccination — protective immunity post-vaccination depends on durable IgG responses exceeding protective thresholds (e.g., anti-tetanus >0.1 IU/mL)
- placenta — FcRn-mediated active transport of maternal IgG provides passive immunity to fetus/neonate until own adaptive immunity matures
- Fc receptors — IgG binds FcγRI (CD64), FcγRIIa (CD32), FcγRIIIa (CD16) on leukocytes triggering phagocytosis, degranulation, or cytotoxicity
- neutrophils — express FcγRIIa enabling rapid phagocytosis of IgG-opsonized bacteria and immune complexes
- immunological memory — IgG production from long-lived plasma cells and memory B cells ensures rapid secondary responses to re-encountered antigens
- C1q — first component of classical complement pathway binds IgG Fc regions (requires 2+ IgG molecules) initiating cascade
- Rheumatoid arthritis — diagnostic markers include rheumatoid factor (IgM/IgG anti-IgG) and ACPA (IgG against citrullinated proteins)
- leaky gut — increased intestinal permeability allows dietary proteins to enter circulation, driving food-specific IgG production in sensitized individuals
- Th1 — IFN-γ from Th1 cells promotes class switching to IgG1 and IgG3 (opsonizing, complement-fixing subclasses)
- IL-4 — Th2 cytokine driving class switch to IgG4 (non-inflammatory, blocking antibody in allergic tolerance)
- chronic inflammation — sustained IL-6 and TNF-α promote plasma cell survival and autoantibody production in autoimmune/chronic infectious states
- FcRn — neonatal Fc receptor rescues IgG from lysosomal degradation via pH-dependent binding, explaining 3-4 week half-life
- GALT — intestinal B cells produce IgA preferentially, but systemic IgG responses occur when antigens breach mucosal barrier
- molecular mimicry — pathogen epitopes resembling self-antigens drive cross-reactive IgG production (e.g., Streptococcal M protein → rheumatic fever anti-cardiac IgG)
- Vitamin D — vitamin D receptor signaling in B cells required for optimal class switching and IgG production; deficiency impairs vaccine responses
- Zinc — essential cofactor for B cell proliferation and antibody synthesis; deficiency reduces IgG levels and increases infection susceptibility